DE69910755D1 - Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen - Google Patents

Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen

Info

Publication number
DE69910755D1
DE69910755D1 DE69910755T DE69910755T DE69910755D1 DE 69910755 D1 DE69910755 D1 DE 69910755D1 DE 69910755 T DE69910755 T DE 69910755T DE 69910755 T DE69910755 T DE 69910755T DE 69910755 D1 DE69910755 D1 DE 69910755D1
Authority
DE
Germany
Prior art keywords
taxols
acyl
resistant cells
multidrug resistant
treating multidrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69910755T
Other languages
English (en)
Other versions
DE69910755T2 (de
Inventor
K Murray
Y Zheng
R Shakya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hauser Inc
Original Assignee
Hauser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hauser Inc filed Critical Hauser Inc
Application granted granted Critical
Publication of DE69910755D1 publication Critical patent/DE69910755D1/de
Publication of DE69910755T2 publication Critical patent/DE69910755T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69910755T 1998-04-10 1999-04-09 Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen Expired - Fee Related DE69910755T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58036 1998-04-10
US09/058,036 US6136988A (en) 1998-04-10 1998-04-10 7-hexanoyltaxol and methods for preparing the same
PCT/US1999/007880 WO1999052887A1 (en) 1998-04-10 1999-04-09 7-hexanoyltaxol and methods for preparing the same

Publications (2)

Publication Number Publication Date
DE69910755D1 true DE69910755D1 (de) 2003-10-02
DE69910755T2 DE69910755T2 (de) 2004-07-01

Family

ID=22014264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69910755T Expired - Fee Related DE69910755T2 (de) 1998-04-10 1999-04-09 Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen

Country Status (8)

Country Link
US (3) US6136988A (de)
EP (1) EP1070057B1 (de)
JP (1) JP2002511457A (de)
AT (1) ATE248156T1 (de)
AU (1) AU757211B2 (de)
CA (1) CA2327791A1 (de)
DE (1) DE69910755T2 (de)
WO (1) WO1999052887A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
WO2000041687A2 (en) * 1999-01-12 2000-07-20 Quanam Medical Corporation Composition and methods for administration of water-insoluble paclitaxel derivatives
WO2000053231A2 (en) * 1999-03-09 2000-09-14 Protarga, Inc. Fatty acid-anticancer conjugates and uses thereof
AU776216B2 (en) * 1999-05-28 2004-09-02 Bristol-Myers Squibb Company Semi-synthesis of paclitaxel using dialkyldichlorosilanes
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
CN1362957A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 作为抗肿瘤剂的c7杂取代乙酸酯取代的紫杉烷
US6624317B1 (en) * 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US20070113575A1 (en) * 2003-12-05 2007-05-24 Ritchie Engineering Company, Inc. Valve manifold assembly
WO2005087222A1 (en) 2004-03-05 2005-09-22 Florida State University Research Foundation, Inc. C7 lactyloxy-substituted taxanes
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
CN101735179B (zh) * 2008-11-19 2012-09-12 上海百灵医药科技有限公司 一种多烯紫杉醇的制备方法，其中间体及制备方法
CN103242267B (zh) * 2012-02-03 2015-03-18 福建南方制药股份有限公司 卡巴他赛及其中间体的制备方法及卡巴他赛中间体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039319A1 (de) 1990-12-10 1992-06-11 Sicowa Verfahrenstech Verfahren zum herstellen von gipsbaustoffen
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
EP0639186B1 (de) * 1992-04-17 1999-06-23 Abbott Laboratories Taxol-derivate
WO1994005282A1 (en) * 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
US5580899A (en) 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same

Also Published As

Publication number Publication date
EP1070057A4 (de) 2001-09-05
CA2327791A1 (en) 1999-10-21
AU3488899A (en) 1999-11-01
AU757211B2 (en) 2003-02-06
US6136988A (en) 2000-10-24
EP1070057A1 (de) 2001-01-24
WO1999052887A1 (en) 1999-10-21
US6753345B2 (en) 2004-06-22
ATE248156T1 (de) 2003-09-15
DE69910755T2 (de) 2004-07-01
EP1070057B1 (de) 2003-08-27
US6469050B1 (en) 2002-10-22
JP2002511457A (ja) 2002-04-16
US20030083367A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69910755D1 (de) Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen
ATE255604T1 (de) Verfahren zur herstellung von polyalkenaminen
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE122006000014I2 (de) Pyranonverbindungen zur Behandlung retroviraler Infektionen
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
DE69501080T2 (de) Verfahren zur herstellung von 7-trialkylsilyl baccatin iii
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE156819T1 (de) Verfahren zur herstellung einer oxazolidincarbon säure nützlich für die herstellung von therapeutischen taxoiden
DE60031269D1 (de) Halbsynthese von paclitaxel mit hilfe von dialkyldichlorsilanen
DE69926223D1 (de) Verfahren zur herstellung von zwischenprodukten
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE69623767D1 (de) Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus
ATE190979T1 (de) Verfahren zur produktion von thiophospholipiden des aether-typs
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
ATE366798T1 (de) Verfahren zur herstellung von pseudomycin aus pseudomonas syringae
ATE232240T1 (de) Verfahren zur herstellung von l-allysin acetal
DE59806420D1 (de) Verfahren zur Behandlung von Cellulosefasern
DE69616801T2 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE69501455D1 (de) Verfahren zur Herstellung von Silizium-Oxy-Karbid
ATE260267T1 (de) Verfahren zur herstellung von c-4-deacetyltaxanen
ATE283863T1 (de) Verfahren zur herstellung von indolopyrrolocarbazol-derivaten
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
DE69620244D1 (de) Verfahren zur herstellung von prostaglandin e1
KR860001066A (ko) 피롤리딘 유도체의 제조방법

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee